Citation, DOI, disclosures and article data
At the time the article was created Andrew Murphy had no recorded disclosures.View Andrew Murphy's current disclosures
Nuclear medicine in vivo is the practice of utilizing small amounts of radioactive substances (unsealed radioactive sources) to diagnose, monitor and treat disease. The utilization of radiopharmaceuticals (radionuclide + pharmaceutical) offers a unique perspective on both disease and cancer treatment. Specifically, only radionuclides that emit γ or β+ radiation find use in nuclear medical imaging. Radionuclides, on the other hand, which are used in therapy emit - as a rule - β- particles.